CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Azelastine

氮卓斯汀 杂质对照品Azelastine Impurities

USPEP36 个杂质条目36 impurity entries

本页汇总 氮卓斯汀 的 36 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 36 impurity reference standards of Azelastine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 氮卓斯汀(Azelastine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesEfficient UPLC and CE methods for the simultaneous determination of azelastine hydrochloride and its genotoxic impurity
    Biomedical chromatography : BMC · 2018 · Abdelwahab NS et al.  ·  PMID 30045415  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and Validation of Stability-Indicating Impurity Profiling Method for Azelastine Hydrochloride and Fluticasone Propionate in Nasal Spray Product Using HPLC with a UV/PDA Detector
    Journal of AOAC International · 2023 · Musmade B et al.  ·  PMID 36929921  ·  DOI
  3. 杂质研究Impurity studiesGreen Analytical Methods for the Separation of Seven Antihistamines: Application in Separation of Azelastine and Related Impurities in Nasal Solution
    International journal of analytical chemistry · 2019 · da Costa LM et al.  ·  PMID 30886632  ·  DOI
  4. 分析方法Analytical MethodsValidated spectroscopic methods for determination of anti-histaminic drug azelastine in pure form: Analytical application for quality control of its pharmaceutical preparations
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2018 · El-Masry AA et al.  ·  PMID 29065333  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法Synthesis[Synthesis of 14C-azelastine hydrochloride]
    Arzneimittel-Forschung · 1983 · Scheffler G et al.  ·  PMID 6686443

氮卓斯汀 —— 原料药与杂质对照品Azelastine — drug substance & impurities

共 37 个条目(含原料药本体)37 items incl. the drug substance
Azelastine structure
USP原料药 APIAPI
氮䓬斯汀Azelastine
Azelastine
CAS No.58581-89-8
Chemical FormulaC22H24ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine EP Impurity A structure
EPA
盐酸氮䓬斯汀杂质3 (盐酸氮䓬斯汀EP杂质A)Azelastine EP Impurity A
Azelastine EP Impurity A
CAS No.613-94-5
Chemical FormulaC7H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Azelastine EP Impurity A structure
EPA
N-Nitroso Azelastine EP Impurity A
CAS No.—
Chemical FormulaC7H7N3O2
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Azelastine EP Impurity B structure
EPB
N-Nitroso Azelastine EP Impurity B
CAS No.—
Chemical FormulaC14H20N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine EP Impurity B DiHCl (Azelastine USP Related Compound B DiHCl) structure
EPB
氮卓斯汀EP杂质BAzelastine EP Impurity B DiHCl (Azelastine USP Related Compound B DiHCl)
Azelastine EP Impurity B DiHCl (Azelastine USP Related Compound B DiHCl)
CAS No.—
Chemical FormulaC14H21N3O.2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine EP Impurity C structure
EPC
盐酸氮䓬斯汀杂质5 (盐酸氮䓬斯汀EP杂质C)Azelastine EP Impurity C
Azelastine EP Impurity C
CAS No.53242-76-5
Chemical FormulaC15H11ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine EP Impurity D (Azelastine USP Related Compound D) structure
EPD
盐酸氮䓬斯汀杂质6 (盐酸氮䓬斯汀EP杂质D)Azelastine EP Impurity D (Azelastine USP Related Compound D)
Azelastine EP Impurity D (Azelastine USP Related Compound D)
CAS No.53242-88-9
Chemical FormulaC15H11ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine EP Impurity E (Z-Isomer) structure
EPE
盐酸氮䓬斯汀杂质16Azelastine EP Impurity E (Z-Isomer)
Azelastine EP Impurity E (Z-Isomer)
CAS No.105279-16-1
Chemical FormulaC15H9ClO2
Purity>95%询价On request
10mg25mg50mg100mg
(S)-Azelastine USP Related Compound F ((S)-Azelastine N-Oxide) (Mixture of Diastereomers) structure
USPF
盐酸氮䓬斯汀杂质10(S)-Azelastine USP Related Compound F ((S)-Azelastine N-Oxide) (Mixture of Diastereomers)
(S)-Azelastine USP Related Compound F ((S)-Azelastine N-Oxide) (Mixture of Diastereomers)
CAS No.1346617-06-8
Chemical FormulaC22H24ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
(R)-Azelastine USP Related Compound F ((R)-Azelastine N-Oxide) (Mixture of Diastereomers) structure
USPF
盐酸氮䓬斯汀杂质9(R)-Azelastine USP Related Compound F ((R)-Azelastine N-Oxide) (Mixture of Diastereomers)
(R)-Azelastine USP Related Compound F ((R)-Azelastine N-Oxide) (Mixture of Diastereomers)
CAS No.1346617-18-2
Chemical FormulaC22H24ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine USP Related Compound F (Azelastine N-Oxide) (Mixture of Diastereomers) structure
USPF
盐酸氮䓬斯汀杂质8Azelastine USP Related Compound F (Azelastine N-Oxide) (Mixture of Diastereomers)
Azelastine USP Related Compound F (Azelastine N-Oxide) (Mixture of Diastereomers)
CAS No.640279-88-5
Chemical FormulaC22H24ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
4-Chlorophenylacetic Acid structure
—
盐酸奥洛他定杂质404-Chlorophenylacetic Acid
4-Chlorophenylacetic Acid
CAS No.1878-66-6
Chemical FormulaC8H7ClO2
Purity>95%询价On request
10mg25mg50mg100mg
N-Desmethyl Azelastine-d4 structure
—
盐酸氮䓬斯汀杂质12-d4 (N-去甲基氮䓬斯汀-d4)N-Desmethyl Azelastine-d4
N-Desmethyl Azelastine-d4
CAS No.2747914-87-8
Chemical FormulaC21H18D4ClN3O
Purity>95%询价On request
N-Desmethyl Azelastine HCl structure
—
盐酸氮䓬斯汀杂质12 盐酸盐 (N-去甲基盐酸氮䓬斯汀)N-Desmethyl Azelastine HCl
N-Desmethyl Azelastine HCl
CAS No.79342-58-8
Chemical FormulaC21H22ClN3O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso N-Desmethyl Azelastine structure
—
N-Nitroso N-Desmethyl Azelastine
CAS No.—
Chemical FormulaC21H21ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
N-Desmethyl Azelastine-d4 HCl structure
—
N-Desmethyl Azelastine-d4 HCl
CAS No.—
Chemical FormulaC21H18D4ClN3O.HCl
Purity>95%询价On request
Azelastine Impurity 1 HCl structure
1
氮卓斯汀杂质1Azelastine Impurity 1 HCl
Azelastine Impurity 1 HCl
CAS No.—
Chemical FormulaC22H24ClN3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 2 HCl structure
2
氮卓斯汀杂质2Azelastine Impurity 2 HCl
Azelastine Impurity 2 HCl
CAS No.—
Chemical FormulaC23H24ClN3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 3 HCl structure
3
氮卓斯汀杂质3Azelastine Impurity 3 HCl
Azelastine Impurity 3 HCl
CAS No.—
Chemical FormulaC23H24ClN3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 4 HCl structure
4
氮卓斯汀杂质4Azelastine Impurity 4 HCl
Azelastine Impurity 4 HCl
CAS No.—
Chemical FormulaC22H24ClN3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 5 HCl structure
5
盐酸氮䓬斯汀杂质13Azelastine Impurity 5 HCl
Azelastine Impurity 5 HCl
CAS No.117078-70-3
Chemical FormulaC22H24ClN3O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 6 DiHCl structure
6
盐酸氮䓬斯汀杂质11Azelastine Impurity 6 DiHCl
Azelastine Impurity 6 DiHCl
CAS No.169123-29-9
Chemical FormulaC7H17N3·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 7 structure
7
盐酸氮䓬斯汀杂质18Azelastine Impurity 7
Azelastine Impurity 7
CAS No.791758-74-2
Chemical FormulaC15H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 8 structure
8
氮卓斯汀杂质8Azelastine Impurity 8
Azelastine Impurity 8
CAS No.6976-17-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 9 HCl structure
9
盐酸氮䓬斯汀杂质17 盐酸盐Azelastine Impurity 9 HCl
Azelastine Impurity 9 HCl
CAS No.89584-24-7
Chemical FormulaC6H13NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 10 structure
10
盐酸氮䓬斯汀杂质22Azelastine Impurity 10
Azelastine Impurity 10
CAS No.1239312-56-1
Chemical FormulaC10H19NO4
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 11 structure
11
氮卓斯汀杂质11Azelastine Impurity 11
Azelastine Impurity 11
CAS No.—
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 12 structure
12
氮卓斯汀杂质12Azelastine Impurity 12
Azelastine Impurity 12
CAS No.—
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 13 structure
13
盐酸氮䓬斯汀杂质21Azelastine Impurity 13
Azelastine Impurity 13
CAS No.50492-22-3
Chemical FormulaC6H11NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 14 HCl structure
14
富马酸氯马斯汀杂质5Azelastine Impurity 14 HCl
Azelastine Impurity 14 HCl
CAS No.19869-42-2
Chemical FormulaC7H14ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 15 (Mixture of Z and E Isomers) structure
15
盐酸氮䓬斯汀杂质29Azelastine Impurity 15 (Mixture of Z and E Isomers)
Azelastine Impurity 15 (Mixture of Z and E Isomers)
CAS No.174826-63-2
Chemical FormulaC9H17N3O
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 16 structure
16
氮卓斯汀杂质16Azelastine Impurity 16
Azelastine Impurity 16
CAS No.—
Chemical FormulaC14H24N2O
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 17 structure
17
氮卓斯汀杂质17Azelastine Impurity 17
Azelastine Impurity 17
CAS No.—
Chemical FormulaC14H24N2O
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 18 HCl structure
18
氮卓斯汀杂质18Azelastine Impurity 18 HCl
Azelastine Impurity 18 HCl
CAS No.—
Chemical FormulaC22H25N3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 19 HCl structure
19
氮卓斯汀杂质19Azelastine Impurity 19 HCl
Azelastine Impurity 19 HCl
CAS No.—
Chemical FormulaC22H24ClN3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Azelastine Impurity 20 HCl structure
20
氮卓斯汀杂质20Azelastine Impurity 20 HCl
Azelastine Impurity 20 HCl
CAS No.—
Chemical FormulaC13H19N3O.HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Azelastine Impurity 20 HCl structure
20
N-Nitroso Azelastine Impurity 20 HCl
CAS No.—
Chemical FormulaC13H18N4O2.HCl
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

氮卓斯汀 —— 研究文献与合成路线Azelastine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 氮卓斯汀 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Azelastine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability study of the antihistamine drug azelastine HCl along with a kinetic investigation and the identification of new degradation products
    El-Shaheny RN, Yamada K · Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2014 · 被引 11cited 11
  2. Development and Validation of Stability-Indicating Impurity Profiling Method for Azelastine Hydrochloride and Fluticasone Propionate in Nasal Spray Product Using HPLC with a UV/PDA Detector
    Musmade B, Korhale R, Sable M, et al. · Journal of AOAC International · 2023 · 被引 2cited 2
  3. Eco-Friendly Green Liquid Chromatographic Determination of Azelastine in the Presence of its Degradation Products: Applications to Degradation Kinetics
    El-Masry AA, Hammouda MEA, El-Wasseef DR, et al. · Journal of AOAC International · 2018 · 被引 5cited 5
  4. Efficient UPLC and CE methods for the simultaneous determination of azelastine hydrochloride and its genotoxic impurity
    Abdelwahab NS, Farid NF, Elagawany M, et al. · Biomedical chromatography : BMC · 2018 · 被引 4cited 4
  5. Green Analytical Methods for the Separation of Seven Antihistamines: Application in Separation of Azelastine and Related Impurities in Nasal Solution
    da Costa LM, Oliveira de Almeida Leite H, Kassab NM, et al. · International journal of analytical chemistry · 2019 · 被引 2cited 2
  6. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies
    Shekhar S, Bali A · Rapid communications in mass spectrometry : RCM · 2024

合成与制备工艺专利Synthesis & process patents

  1. SOLUTION-TYPE PREPARATION CONTAINING AZELASTINE
    GIL YOUNG SIG, WOO SEOK JE, CHO HONG KOO · 公开号 KR20100010208KR20100010208 · 2010
  2. Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
    MIZOBUCHI NORIKO, SETO SAYURI · 公开号 HK1021329HK1021329 · 2005
  3. Stable preparation containing azelastine hydrochloride
    Morita Yutaka, Koyama Noritosi, Ohsawa Sigemitu · 公开号 EP0580074EP0580074 · 1994
  4. Azelastine embonate, process for its preparation and pharmaceutical preparations which contain azelastine embonate as an active ingredient
    SCHEFFLER GERHARD DR, SAUERBIER DIETER, ENGEL JUERGEN DR · 公开号 DE3836749DE3836749 · 1989
  5. AZELASTINE HYDROCHLORIDE-CONTAINING PERCUTANEOUS PREPARATION HAVING GOOD PERCUTANEOUS ABSORBABILITY AND REDUCED SKIN IRRITATION
    MIZOBUCHI Noriko, SETO Sayuri · 公开号 WO9901137WO9901137 · 1999

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

氮卓斯汀 杂质谱研究要点Azelastine — impurity profiling notes

下面这些是拿到 氮卓斯汀 的 37 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 37 impurity entries for Azelastine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances